Taking stock of the drug industry, from the lab to the medicine chest

June 26, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

CDC CDC advisory panel opts for a go-slow approach on expanding usage of RSV vaccines An advisory committee recommended changes that will likely see fewer older adults qualify for insurance coverage for the products. By Helen Branswell STAT+ | Biotech accelerator Curie.Bio extends its reach with new $380 million fund The money will mostly be invested in other biotechs that go through the accelerator and go on to raise a Series A round. By Allison DeAngelis STAT+ | Q&A: How Flagship's Cellarity is using AI to understand cell disease biology before treating it Cellarity says it's using AI "to unravel the complexities of disease biology to produce 'game-changing' medicines out of reach previously." By Brittany Trang Adobe Opinion: FDA: Don't rush publishing your diversity guidance plan. Take your time and do it right The FDA is late publishing guidance on clinical trial diversity action plans. If that means it's trying to get it right, the delay is OK. By Tamei Elliott and Maria Vassileva

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser